Breakthrough Phase 3 Results for Ziihera® in Cancer Treatment
Significant Advances in Cancer Treatment with Ziihera® Zymeworks Inc., a pioneering biotechnology company, has recently shared groundbreaking results from the Phase 3 HERIZON-GEA-01 trial. This trial assessed the efficacy of Ziihera® (zanidatamab-hrii) when paired with chemotherapy, aiming to provide a new standard of care for patients with HER2-positive locally...
Continue Reading